Preoperative HIIT in Elderly Cancer Patients
eHIITCa
A Randomised Control Trial to Assess Efficacy of Preoperative High Intensity Interval Training in Elderly Patients Scheduled for Oncological Abdominal Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
This randomized control trial will determine the effect of short term high intensity interval training (HIIT) on physical fitness, in an elderly patient group with active cancer, prior to surgical resection. Half of the recruited patients will act as a control group and the other half will undergo a HIIT protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Aug 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2016
CompletedFirst Posted
Study publicly available on registry
February 2, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedSeptember 14, 2018
September 1, 2018
1.9 years
January 18, 2016
September 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2AT (VO2 at anaerobic threshold)
Change in anaerobic threshold seen during maximal exercise test (pre and post intervention).
Baseline and 4 weeks
Secondary Outcomes (3)
VO2peak
Baseline and 4 weeks
Subjective acceptability of HIIT preoperatively (via questionnaire)
After 4 weeks of HIIT.
Muscle protein synthesis rate changes with HIIT.
Baseline and 4 weeks.
Study Arms (2)
Control
NO INTERVENTIONControl: This group of patients will receive 'current best practice' as per UK NHS recommendations for their specific cancer management prior to surgery.
High intensity interval training
EXPERIMENTALExercise: Participants in this group will attend 3-4 times per week to complete HIIT training during the period from diagnosis to surgery. High intensity interval training (HIIT)
Interventions
Preoperative HIIT protocol.
Eligibility Criteria
You may qualify if:
- Aged over 65 years (no upper age limit).
- Histologically proven, radiologically or direct visualisation leading to high clinical suspicion of cancer.
- Sufficient mobility to be able to exercise on a static exercise bike.
- Ability to give informed consent.
- Ability to travel to RDH to complete the HIIT sessions (may also rely upon dependents/relatives to provide transport).
You may not qualify if:
- Adjuvant systemic chemotherapy / radiotherapy treatment for this cancer. Participants with a significant past medical history of:
- Myocardial infarction (within last 6 months)
- Unstable Angina
- Heart failure (NYHA class III/IV)
- Uncontrolled Hypertension (BP\>160/100)
- Previous stroke/TIA
- Severe respiratory disease inc. known pulmonary hypertension(\>25 mmHg), Forced Expiratory Volume in 1 second \<1.5l.
- Brittle asthma / exercise induced asthma
- Known cerebral aneurysm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Derby Hospital
Derby, Derbyshire, DE22 3NE, United Kingdom
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Williams, MBChB FRCA PhD
Nottingham University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 18, 2016
First Posted
February 2, 2016
Study Start
August 1, 2016
Primary Completion
July 1, 2018
Study Completion
August 1, 2018
Last Updated
September 14, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share
No individual patient data will be made available.